Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Net Asset Value(s)

27 Dec 2023 09:17

RNS Number : 8121X
Ceiba Investments Limited
27 December 2023
 

CEIBA INVESTMENTS LIMITED

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

 

UNAUDITED NET ASSET VALUE PER SHARE AS AT 30 SEPTEMBER 2023

 

 

CEIBA Investments Limited (the "Company"), the largest listed foreign investor solely dedicated to investing in Cuba, announces that its unaudited net asset value per share ("NAV") as at 30 September 2023 was USD1.1818 (30 June 2023: USD1.0929). Applying the GBP:USD exchange rate as at 30 September 2023 of USD1.2207:GBP1.00 (30 June 2023: USD1.2714:GBP1.00), the unaudited NAV in Sterling was GBP0.9681 (30 June 2023: GBP0.8596) per share.

As at 30 September 2023, the net assets were USD162,704,949 (30 June 2023: USD150,461,312).

Management Commentary

The increase of NAV is primarily the result of the Company having been able to unlock USD14.3 million of previously provisioned dividends owed by Inmobiliaria Monte Barreto S.A. ("Monte Barreto") to CEIBA MTC Inc.

In September 2023, the Spanish hotel company HOMASI S.A., holder of 50% of the shares in the capital of Miramar S.A., the Cuban joint venture company that owns and operates four hotels in Havana and Varadero, increased its capital by ?20,714,285.70. The Company, which has a 65% shareholding interest in HOMASI S.A., made its capital contribution by transferring USD14.3 million in dividends owed by Monte Barreto to the bank account of Miramar S.A. as a capital contribution to fund its existing CAPEX and investment programs. The matching USD14.3 million capital contribution to be made by the Cuban (50%) shareholder CUBANACAN S.A. in Miramar S.A. will be made by extending the surface rights of the joint venture's hotel properties in Havana and Varadero and the term of the Cuban joint venture company.

During the third quarter the Company received approximately USD1.8 million in dividend income from Miramar S.A., which was largely offset by expenses, bond interest payments and forex (loss).

 

 

For further information, please contact:

 

Sebastiaan Berger

 

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Finn Gordon (Corporate Finance)

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

 

 

www.ceibainvest.com

 

END OF ANNOUNCEMENT

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVPPGWGPUPWUBM
12
Date   Source Headline
3rd Jul 20234:41 pmRNSUpdate re Internalisation of Management
28th Jun 20236:16 pmRNSResult of AGM
28th Jun 20236:05 pmRNSNet Asset Value(s)
27th Apr 20234:03 pmRNSAnnual Financial Report - Replacement
27th Apr 20237:00 amRNSInternalisation of Management
27th Apr 20237:00 amRNSAnnual Financial Report
7th Feb 20231:07 pmRNSHolding(s) in Company
14th Dec 20221:14 pmRNSCorrection: Half-year Report
1st Dec 20227:00 amRNSService Providers and Registered Office
30th Nov 202212:22 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
1st Aug 20224:53 pmRNSAlternative Investment Fund Manager–Change of Name
4th Jul 202210:02 amRNSNet Asset Value(s)
16th Jun 20225:34 pmRNSResult of AGM
25th May 20223:38 pmRNSCorrection: Annual Financial Report
29th Apr 20229:45 amRNSAnnual Financial Report
23rd Feb 20227:00 amRNSNet Asset Value(s)
22nd Feb 20227:00 amRNSTrading Update
19th Jan 20224:48 pmRNSHolding(s) in Company
31st Dec 20211:27 pmRNSHolding(s) in Company
31st Dec 20211:26 pmRNSHolding(s) in Company
26th Nov 20214:34 pmRNSHolding(s) in Company
26th Nov 20213:24 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
28th Sep 20217:00 amRNSHalf-year Report
17th Jun 20212:47 pmRNSResult of AGM
28th Apr 20217:00 amRNSAnnual Financial Report
14th Apr 20217:00 amRNSListing of Convertible Bonds
31st Mar 202112:16 pmRNSTrading Statement
15th Jan 20217:00 amRNSNet Asset Value(s)
16th Dec 20207:00 amRNSTrading Statement
3rd Dec 20204:30 pmRNSResult of Extraordinary Meeting
13th Nov 20207:00 amRNSNotice of EGM
23rd Oct 20207:00 amRNSTrading Statement
9th Oct 20204:59 pmRNSHalf-year Report
29th Sep 20207:00 amRNSHalf-year Report
19th Jun 20204:00 pmRNSResult of AGM
8th Jun 20207:00 amRNSTrading Statement
20th May 20205:40 pmRNSNet Asset Value(s)
28th Apr 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSTrading Statement
3rd Dec 20193:37 pmRNSChange of Auditor
6th Nov 201912:32 pmRNSNet Asset Value(s)
30th Sep 20197:00 amRNSHalf-year Report
18th Jun 20195:27 pmRNSResult of AGM
13th Jun 20194:38 pmRNSHolding(s) in Company
11th Jun 201910:53 amRNSPublication of Supplementary Prospectus
3rd Jun 201912:59 pmRNSTrading Statement
29th May 201911:29 amRNSNet Asset Value(s)
30th Apr 20195:40 pmRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.